22157.jpg
Global Diabetes Diagnostics Market Report 2021: Market to Reach $42.4 Billion by 2026 - U.S. Market is Estimated at $10.8 Billion, While China is Forecast to Reach $5.2 Billion
July 20, 2021 04:33 ET | Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Diabetes Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Diabetes...
Imara-Logo-Color-RGB.jpg
Imara Announces Recipients of the Second Annual Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders
June 17, 2021 07:00 ET | Imara, Inc.
BOSTON, June 17, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
Imara-Logo-Color-RGB.jpg
Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress
June 11, 2021 03:00 ET | Imara, Inc.
Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on IMR-687 Interim open-label extension clinical trial...
22157.jpg
Global Sickle Cell Anemia Market Report 2021-2031: Key Marketed and Pipeline Drugs, Clinical Trials, Recent Events, Regulatory Events, Success Probability, Disease Prevalence, Licensing & Acquisition
June 09, 2021 08:53 ET | Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Sickle Cell Anemia" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Sickle Cell...
22157.jpg
Worldwide Hemoglobin Testing Industry to 2026 - Players Include Abbott, Bio-Rad Laboratories and Danaher Among Others
May 14, 2021 06:53 ET | Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Imara-Logo-Color-RGB.jpg
Imara to Webcast Conference Call of First Quarter 2021 Financial Results and Business Highlights
May 04, 2021 07:00 ET | Imara, Inc.
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
22157.jpg
Global Hemoglobin A1C Monitoring Market Report 2021-2027 - U.S. Market is Estimated at $275.9 Million, While China is Forecast to Grow at 11.8% CAGR
April 23, 2021 05:33 ET | Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Hemoglobin A1C Monitoring - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Hemoglobin...
GBT new logo.png
Global Blood Therapeutics Announces Participation at Three September Conferences
September 03, 2015 07:35 ET | Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...
22157.jpg
Hemoglobin A1c Testing Market to Spike to $1.6 Billion by 2017
September 27, 2013 07:21 ET | Research and Markets
Dublin, Sept. 27, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/3k6s99/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c...
HemaQuest Pharmaceuticals Receives European Orphan Medicinal Product Designations for Therapeutic to Treat Hemoglobin Disorders
March 26, 2009 12:54 ET | HemaQuest Pharmaceuticals
BOSTON, MA--(Marketwire - March 26, 2009) - HemaQuest Pharmaceuticals today announced that it has received two orphan medicinal product designations from the European Commission for its product...